Keyword :   targeted therapy

Therapeutic options for breast cancer with low HER2/NEU expression
Authors: Chovgan O.E. Samuseva A.A. Lyalkin S.A. Т. 15, №4 (60)
Treatment with tyrosine kinase inhibitors in patients with metastatic differentiated thyroid cancer refractory to radioiodine therapy
Authors: Solodiannykova O.I. Danylenko V.V. Т. 15, №4 (60)
Lung oncology: a new era in therapy
Т. 15, №3 (59)
Management strategy for gastrointestinal stromal tumors (GIST): current status and future perspectives
Authors: Kondratskyi Yu.M. Koval N.O. Kolesnyk A.V. Kozak E.O.... Т. 15, №2 (58)
Side effects of iodine-negative thyroid cancer targeted therapy
Authors: Solodyannikova O.I. Bankovska N.V. Danylenko V.V. Turitsyna V.L. Т. 15, №1 (57)
From theory to practice. The art of lung cancer treatment
Т. 14, №3 (55)
Zirabev as a representative of the largest family of biosimilars in oncology
Т. 14, №3 (55)
Sorafenib in the treatment of iodine-negative differentiated thyroid cancer
Authors: Solodiannykova O.I. Kmetyuk Y.V. Stolyarova O.Yu. Danylenko V.V.... Т. 14, №2 (54)
Induction targeted therapy with tyrosine kinase inhibitors in the treatment of EGFR-positive non-small cell lung cancer. Clinical case and discussion of features of therapeutic «targeted» tumor pathomorphosis
Authors: Sukhoversha O.A. Tsyhankov K.V. Kuzhevskyi I.V. Koval S.S. Т. 13, № 2 (50)
Treatment of patients with Hodgkin’s lymphoma after progression: chemosensitivity, transplantation and targeted drugs
Authors: Rudiuk T. Novosad O. Kryachok I. Т. 12, № 1-2 (45-46)
The role of targeted therapy in the treatment of patients with EGFR+ mutations of lung cancer (review)
Authors: Kolesnik O.P. Shevchenco A.I. Kadzhoian A.V. Kuzmenko V.A.... Т. 8, № 3 (31) 2018
Modern approaches to neoadjuvant therapy in patients with esophageal cancer
Authors: Kirkilevskyi S.I. Frydel R.I. Krahmalyov P.S. Kondratskyi Y. №3(19) 2015
Treatment of patients with advanced cutaneous melanoma: current approaches and perspectives
Authors: Kukushkina M.M. Korovin S.I. Palivets A. Ostafiychuk V.V.... №4(16) 2014
Chemotherapy and targeted therapy combination in patients with platinum-resistant ovarian cancer: case report
Authors: Kuznetsova O.V. Tchebotariova Rybin,G.M. Marzynkivska,A.I. N.V. Rybin A.I. №3(15) 2014
A clinical study of the efficacy of paclitaxel and bevacizumab as first-line therapy for HER2-negative breast cancer
№1(9) 2013